leisure time -WSS

leisure time

author：focus 2025-08-23 03:45:02 - browse：37331

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Pediatricians' group reaffirms support for gender

WSS

Prosecutors seek bail revocation for FTX founder Sam Bankman

Timeline: Key moments in fight for gay rights

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Living organ donors deserve priority status for transplants

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

leisure time

leisure time

focus

Affirmative action in medical school literally saved lives

Medical mystery: When an infection after surgery isn’t what it seems

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Xenotransplantation trials will require adjusting expectations, experts say

Cancer drug shortages should be causing more outrage

How to fix the rural physician shortage in the U.S.

ChatGPT in medicine: STAT answers readers' burning questions

Rock icon Freddie Mercury pre

What does generative AI mean for health care? We asked experts

Eat, drink, but be wary — 4 foods that interact with medications

explore

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Can medical device makers keep up in the race to treat obesity?

Eat, drink, but be wary — 4 foods that interact with medications

Pharma needs to include young adults in clinical research

Altering the blood type of lungs raises potential for universal organs for transplants

focus

leisure time

hotspot

entertainment